Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease-Reference-Cited by-同舟云学术

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease

Published:2012-08-13 Issue:9 Volume:3 Page:731-735
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Prime Michael E.¹,Brookfield Frederick A.¹,Courtney Stephen M.¹,Gaines Simon¹,Marston Richard W.¹,Ichihara Osamu¹,Li Marie¹,Vaidya Darshan¹,Williams Helen¹,Pedret-Dunn Anna¹,Reed Laura¹,Schaertl Sabine²,Toledo-Sherman Leticia³,Beconi Maria³,Macdonald Douglas³,Muñoz-Sanjuan Ignacio³,Dominguez Celia³,Wityak John³

Affiliation:

1. Evotec (U.K.) Ltd., 114 Milton Park, Abingdon OX14 4SA, United Kingdom

2. Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany

3. CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 100, Los Angeles, California 90045, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml3001352

Reference21 articles.

1. Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues